Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label in the footer changed from 'Revision: v3.2.0' to 'Revision: v3.3.2'.SummaryDifference0.1%

- Check20 days agoChange Detected- Removed the government funding status notice from the study page, which previously warned that information may not be up to date due to funding delays.SummaryDifference0.4%

- Check34 days agoChange DetectedThe changes appear limited to layout and formatting updates with no modifications to core study details such as purpose, endpoints, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

- Check69 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0; overall content remains the same except the revision identifier.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.